HOXB2 as a Novel Prognostic Indicator for Stage I Lung Adenocarcinomas
Open Access
- 1 September 2007
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 2 (9) , 802-807
- https://doi.org/10.1097/jto.0b013e3181461987
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneityHuman Pathology, 2007
- A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung CancerNew England Journal of Medicine, 2006
- Current Concepts in Bronchioloalveolar Carcinoma BiologyClinical Cancer Research, 2006
- Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A ReviewClinical Cancer Research, 2005
- Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugsOncogene, 2003
- Early-Stage Lung Adenocarcinomas With a Micropapillary Pattern, a Distinct Pathologic Marker for a Significantly Poor PrognosisThe American Journal of Surgical Pathology, 2003
- Prognostic Factors in Non-small Cell Lung CancerChest, 2002
- A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markersThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Revisions in the International System for Staging Lung CancerChest, 1997
- HOMEOTIC GENES AND THE HOMEOBOXAnnual Review of Genetics, 1986